Welcome to the Department of Medicine
Latest News
-
Edward Sheen on his experience as a White House Fellow
In a recent interview, Edward Sheen shared his experience as a fellow, discussed his commitment to public service and offered advice to prospective applicants.
-
A service center to help you do your research
If you are a physician without a lab or a scientist needing research guidance or services, the Translational Applications Service Center (TASC) might be just what you’re looking for.
-
Postdoctoral researcher Junaid Zaman receives inaugural UK-US Fulbright British Heart Foundation Research Scholar Award
Junaid Zaman, MD, PhD, a postdoctoral researcher at Imperial College London and Stanford University, has received the inaugural UK-US Fulbright British Heart Foundation Research Scholar Award.
-
Taking Direct Aim at AML
“My long-term goal is to make an impact on outcomes of patients with AML. That’s my personal mission and vision. We are treating them with same crappy chemotherapy drugs that were being used in the 1980s, and patients don’t do well. We need to bring them new approaches.”…
Department Events
Faculty Activities Of Note
Faculty Spotlight: Shivaani Kummar, MD, FACP
What routes do new faculty take as they wend their way through post-doctoral training to prepare for where life leads them? In particular, what routes do new Stanford Department of Medicine faculty follow? What leads them to take the fork in the road that ends up on the Stanford campus?
Patient-Knows-Best Research Trials
In the latest episode of “The Bob Harrington Show” on Medscape’s theheart.org, Drs Harrington and Hernandez discuss the limitations of randomized trials and the upcoming adaptable trial on aspirin dosing developed under the patient-centered-outcomes research initiative from NIH.
Baseline Study Town Hall Meeting
The School of Medicine hosted a Town Hall meeting on March 20, 2015 to share and discuss an exciting research endeavor called the “Baseline Study”. Baseline is a clinical research collaboration between Google Life Sciences, Stanford University School of Medicine, and Duke University School of Medicine to develop an integrated understanding of human health and the transition to disease. The overall goal of the Baseline Study is to develop a comprehensive understanding of health and disease state transitions for more focused preventive measures, timely and targeted preemptive interventions, and a better development of new therapeutics and diagnostics.
A video recording of the Baseline Town Hall Meeting is available to the Stanford community, accessible only with a valid SUNet ID and password.
Divisions in the Department of Medicine
At the Stanford Center for Biomedical Research (BMIR) we develop cutting-edge ways to acquire, represent, and process information about human health.
In order to handle the ever increasing amounts of data in healthcare and biomedical research, our faculty, students, and staff investigate and create novel computational, statistical, organizational, and decision-making methods. Our research advances the state of the art in semantic technology, biostatistics, and the modeling of biomedical systems to benefit clinical and translational research as well as patient care.
The BMT program at Stanford performs autologous and allogeneic transplantations for over 300 patients each year. The program has been very successful with a history of limited morbidity rates and acute mortality that is well below most published reports.
In addition to a successful clinical practice, our program researchers are translating their discoveries into new therapies, advancing the efficacy of hematopoietic cell transplantation for patients worldwide.
The Division of Cardiovascular Medicine is a dynamic and innovative center dedicated to excellence in research, medical education, and clinical care. Our division is driven by over 40 faculty, clinician educators and instructors who are the pillar of strength in the Division’s ongoing efforts into the prevention, and treatment of cardiovascular disease.
The division of Endocrinology, Gerontology and Metabolism has a long history of major contributions in basic and clinical research, a record of training fellows for academic and clinical careers, and a commitment to providing care for patients with complex endocrine diseases.
The basic science and clinical studies that are carried out at Stanford University cover a broad range of areas in endocrinology, diabetes and metabolism. Through our integrated research, education, patient and community outreach programs, we are committed to maintaining the highest standards of academic medicine and patient care.
The Division of Gastroenterology and Hepatology has a long tradition of major contributions in basic research, a new commitment to clinical and outcomes research, a track record of training fellows for academic careers, and a longitudinal commitment to providing care for patients with complex gastrointestinal and liver diseases.
The Division of General Medical Disciplines is committed to training the next generation of academic general internists and practitioners. While engaged in practice and teaching, our faculty are dedicated as well to establishing new knowledge as the basis for future practice and prevention, and to the greatest extent possible applying that knowledge to improve care for all and reduce health disparities.
The Division of Hematology is a progressive and dynamic center for basic and translational science, clinical research, patient care, and teaching, where clinicians, scholars, investigators, and trainees work together to harness the power and resources of Stanford Medicine in the pursuit of excellence.
The Division is dedicated to institutional and community commitment to the development of research programs at Stanford that focus on clinical immunology. The Division of Immunology and Rheumatology has a longstanding tradition of excellence in patient care, and is among the leading groups in the School of Medicine in cutting edge bench research, clinical trial investigation and outcomes assessment research.
Our Division encompasses all aspects of infectious diseases and geographic medicine, including clinical microbiology, hospital epidemiology, AIDS, international health, mechanisms of pathogenesis, the role of microbes in chronic & unexplained disease, human microbial ecology, parasitology, microbial & viral genomics, and tropical medicine.
The Division of Nephrology is the branch of internal medicine devoted to the study, diagnosis, and treatment of kidney disease. The Division of Nephrology in the Department of Medicine offers fellows and faculty unparalleled prospects for research and clinical training in an atmosphere with ample opportunity to participate in University and community service, in an exciting academic environment committed to excellence, innovation and diversity.
Emerging science, new technology, and improvements in diagnostics and patient care have enabled nephrologists to treat kidney and renal disease more successfully. Stanford Hospital is proud to once again be recognized in the 2013 US News & World Report “ Best Hospitals Survey as one of the best centers for the treatment of kidney disease.
The work of the Division of Oncology bridges the worlds of basic science, clinical diagnosis and the treatment of cancer. Our basic investigative activities concentrate on immunology, genetics/genomics, pharmacology, DNA repair and oncogene action. Our clinical science covers each cancer type; has a strong focus in clinical trials of new diagnostic and therapeutic approaches, and in correlative laboratory studies. Our work is supported by a portfolio of peer-reviewed grants, industrial agreements and research endowments.
Stanford Health Policy is the joint working name of the Center for Health Policy (CHP) and the Center for Primary Care and Outcomes Research (PCOR). We conduct rigorous research that lays the foundation for better domestic and international health policy and health care. Drawing upon our multidisciplinary research, Stanford Health Policy offers innovative educational programs from the undergraduate to the graduate level.
The Division of Pulmonary and Critical Care Medicine (PCCM) is comprised of a team of outstanding clinicians, scientists, and scholars dedicated to improving the lives of patients with serious lung disease. Our goal is to provide outstanding clinical and research training to the next generation of leaders in Pulmonary and Critical Care Medicine. We are committed to strong clinical investigations including the evaluation of new pharmacologic agents, which offer potentially promising therapeutic benefits, as well as outcome studies which characterize clinical parameters to effect positive changes in patient care.
The Stanford Prevention Research Center (SPRC) is a consortium of renowned experts who are world leaders in investigating ways to prevent disease and promote health. Their work is focused on identifying the most practical, science-based solutions for addressing some of society’s most pervasive—and preventable—health issues, such as obesity, diabetes, hypertension, and other chronic conditions and to raise the standards of scientific investigation that matters for health. SPRC investigators are collaborating on numerous, long-term projects designed to translate research into effective ways to promote well-being at every stage of life.